Scopus BioPharma Inc (SCPS)
0.0021
0.00 (0.00%)
USD |
OTCM |
May 20, 16:00
Scopus BioPharma Cash from Investing (TTM): 0.00 for June 30, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
June 30, 2023 | 0.00 |
March 31, 2023 | 0.00 |
December 31, 2022 | -0.0016M |
September 30, 2022 | -0.0016M |
June 30, 2022 | -0.0036M |
Date | Value |
---|---|
March 31, 2022 | -0.0036M |
December 31, 2021 | -0.002M |
September 30, 2021 | -0.002M |
June 30, 2021 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-0.0036M
Minimum
Mar 2022
--
Maximum
Jun 2021
-0.0016M
Average
-0.0016M
Median
Sep 2022
Cash from Investing (TTM) Benchmarks
NovaBay Pharmaceuticals Inc | 1.062M |
Palatin Technologies Inc | 9.41M |
iBio Inc | 1.044M |
Theriva Biologics Inc | -0.194M |
Oragenics Inc | -- |